Description
This product utilizes Cytokine-Induced T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD44 (clone F1G0Z-4I4I-2E). We employs the HBV (trc-Cy3-ER-XbaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Balancing feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD44
Clone
F1G0Z-4I4I-2E
Species Reactivity
Human
Cell Source
Cytokine-Induced T cells
Sensor Gene
Cy3
Promoter
trc
Effector Gene
ER
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.89
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.